Anika Therapeutics (ANIK) Competitors $14.38 +0.29 (+2.06%) As of 04/24/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ANIK vs. CERS, OSUR, UTMD, COO, WST, ALGN, MMSI, ICUI, HAE, and XRAYShould you be buying Anika Therapeutics stock or one of its competitors? The main competitors of Anika Therapeutics include Cerus (CERS), OraSure Technologies (OSUR), Utah Medical Products (UTMD), Cooper Companies (COO), West Pharmaceutical Services (WST), Align Technology (ALGN), Merit Medical Systems (MMSI), ICU Medical (ICUI), Haemonetics (HAE), and DENTSPLY SIRONA (XRAY). These companies are all part of the "health care supplies" industry. Anika Therapeutics vs. Cerus OraSure Technologies Utah Medical Products Cooper Companies West Pharmaceutical Services Align Technology Merit Medical Systems ICU Medical Haemonetics DENTSPLY SIRONA Cerus (NASDAQ:CERS) and Anika Therapeutics (NASDAQ:ANIK) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, community ranking, analyst recommendations, earnings, institutional ownership, profitability, media sentiment, risk and dividends. Is CERS or ANIK more profitable? Cerus has a net margin of -11.60% compared to Anika Therapeutics' net margin of -59.40%. Anika Therapeutics' return on equity of -2.22% beat Cerus' return on equity.Company Net Margins Return on Equity Return on Assets Cerus-11.60% -40.55% -11.12% Anika Therapeutics -59.40%-2.22%-1.75% Do analysts prefer CERS or ANIK? Cerus currently has a consensus price target of $3.50, suggesting a potential upside of 157.35%. Anika Therapeutics has a consensus price target of $21.67, suggesting a potential upside of 50.67%. Given Cerus' higher possible upside, analysts plainly believe Cerus is more favorable than Anika Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cerus 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Anika Therapeutics 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.00 Which has more volatility and risk, CERS or ANIK? Cerus has a beta of 1.7, meaning that its stock price is 70% more volatile than the S&P 500. Comparatively, Anika Therapeutics has a beta of 0.82, meaning that its stock price is 18% less volatile than the S&P 500. Do institutionals and insiders hold more shares of CERS or ANIK? 78.4% of Cerus shares are held by institutional investors. Comparatively, 91.5% of Anika Therapeutics shares are held by institutional investors. 3.4% of Cerus shares are held by company insiders. Comparatively, 7.9% of Anika Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Does the MarketBeat Community prefer CERS or ANIK? Cerus received 263 more outperform votes than Anika Therapeutics when rated by MarketBeat users. Likewise, 72.34% of users gave Cerus an outperform vote while only 64.63% of users gave Anika Therapeutics an outperform vote. CompanyUnderperformOutperformCerusOutperform Votes57072.34% Underperform Votes21827.66% Anika TherapeuticsOutperform Votes30764.63% Underperform Votes16835.37% Does the media prefer CERS or ANIK? In the previous week, Anika Therapeutics had 5 more articles in the media than Cerus. MarketBeat recorded 7 mentions for Anika Therapeutics and 2 mentions for Cerus. Anika Therapeutics' average media sentiment score of 0.68 beat Cerus' score of 0.66 indicating that Anika Therapeutics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cerus 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Anika Therapeutics 2 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Which has stronger valuation & earnings, CERS or ANIK? Cerus has higher revenue and earnings than Anika Therapeutics. Cerus is trading at a lower price-to-earnings ratio than Anika Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCerus$180.27M1.40-$37.49M-$0.11-12.36Anika Therapeutics$119.91M1.70-$82.67M-$3.85-3.74 SummaryCerus and Anika Therapeutics tied by winning 9 of the 18 factors compared between the two stocks. Get Anika Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ANIK and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ANIK vs. The Competition Export to ExcelMetricAnika TherapeuticsSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$203.85M$4.25B$5.41B$7.70BDividend YieldN/A46.48%5.44%4.33%P/E Ratio-2.1629.7422.1818.31Price / Sales1.7051.38397.31107.09Price / Cash3.5351.0838.2034.62Price / Book0.996.076.834.25Net Income-$82.67M$67.09M$3.20B$247.51M7 Day Performance2.57%4.11%5.79%6.08%1 Month Performance-7.17%-9.37%-5.53%-3.77%1 Year Performance-44.48%24.52%16.85%4.60% Anika Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ANIKAnika Therapeutics4.1669 of 5 stars$14.38+2.1%$21.67+50.7%-44.5%$203.85M$119.91M-2.16300CERSCerus2.3904 of 5 stars$1.36-1.4%$3.50+157.4%-18.1%$252.67M$180.27M-12.36290Upcoming EarningsOSUROraSure Technologies4.6752 of 5 stars$3.00+2.4%$5.50+83.3%-44.9%$224.40M$185.83M20.00840Positive NewsUTMDUtah Medical Products3.0297 of 5 stars$53.32+0.5%N/A-21.3%$175.00M$40.90M13.50180COOCooper Companies3.13 of 5 stars$78.76+1.7%$110.25+40.0%-8.4%$15.75B$3.93B40.3916,000WSTWest Pharmaceutical Services4.7006 of 5 stars$212.74+1.0%$332.50+56.3%-45.4%$15.38B$2.89B31.8010,700Earnings ReportDividend AnnouncementNews CoverageALGNAlign Technology4.5571 of 5 stars$165.62+0.9%$262.64+58.6%-41.3%$12.13B$4.00B29.5221,610Upcoming EarningsAnalyst ForecastMMSIMerit Medical Systems4.528 of 5 stars$93.25+1.3%$114.33+22.6%+27.9%$5.51B$1.36B45.716,850Earnings ReportAnalyst ForecastNews CoveragePositive NewsICUIICU Medical3.7636 of 5 stars$140.54-1.5%$168.67+20.0%+41.8%$3.45B$2.38B-30.7514,500Analyst DowngradeNews CoverageHAEHaemonetics4.6229 of 5 stars$59.29-1.2%$101.22+70.7%-28.2%$2.98B$1.37B23.342,820News CoveragePositive NewsXRAYDENTSPLY SIRONA4.8522 of 5 stars$13.08+2.4%$23.33+78.4%-55.7%$2.60B$3.79B-6.3215,000Positive News Related Companies and Tools Related Companies Cerus Alternatives OraSure Technologies Alternatives Utah Medical Products Alternatives Cooper Companies Alternatives West Pharmaceutical Services Alternatives Align Technology Alternatives Merit Medical Systems Alternatives ICU Medical Alternatives Haemonetics Alternatives DENTSPLY SIRONA Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ANIK) was last updated on 4/25/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredTrump purposefully forcing markets to crash…Whether you agree with the plan or not doesn’t matter. It’s happening. The only question is – are you re...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredAmazon ShockerJeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical t...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Anika Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Anika Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ANIK Stock Free ANIK Stock Alerts